CHENGDU KANGHONG BIOTECHNOLOGIES CO LTD has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in Brazil, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ZYMOGENETICS INC, BIOTIE THERAPIES LTD and AMUNIX OPERATING INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 5 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Republic of Korea | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Australia | 2 | |
#7 | United States | 2 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | Peru | 1 | |
#13 | Singapore | 1 | |
#14 | Ukraine | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ke Xiao | 20 |
#2 | Gao Xiaoping | 17 |
#3 | Ke Zunhong | 3 |
#4 | Xiao Ke | 2 |
#5 | Liu Zheng | 2 |
#6 | Xiaoping Gao | 2 |
#7 | Zunhong Ke | 1 |
#8 | Yo Michael Dechao | 1 |
#9 | Lei Gang | 1 |
#10 | Jiangsu | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017129064A1 | Humanized fab of anti-complement factor d and humanized antibody and use thereof | |
AU2015208482A1 | Fusion protein inhibiting angiogenesis or growth and use thereof | |
WO2012041018A1 | ANTI TNF α HUMANIZED ANTIBODY AND FRAGMENT ANTIGEN BINDING (FAB) AND USE THEREOF | |
BRPI0710223A2 | vegf receptor fusion proteins and their use | |
CA2569108A1 | Angiogenesis-inhibiting chimeric protein and the use | |
BRPI0418805A | construction of oncolytic adenovirus recombinant expressing specifically a gmcsf immunomodulatory factor in tumor cells and their uses |